Phase I trial of 1alpha-hydroxyvitamin d(2) in patients with hormone refractory prostate cancer.
暂无分享,去创建一个
R. Mazess | G. Wilding | R. Bruskewitz | H. Bailey | Abhik Bhattacharya | R. Arzoomanian | D. Alberti | Glenn Liu | G. Ripple | M. Staab | K. Oettel | R. Marnocha | C. Bishop | D. Horvath